Fig. 1From: Neoantigens and their clinical applications in human gastrointestinal cancersThe typical recognition of tumor neoantigens by immune cells. The tumor-specific neoantigens derived from genetic alterations such as mutated DNA or altered ORF are presented by APCs and recognized as foreign molecules by the adaptive immune cellsBack to article page